CN110452142B - Preparation method of S- (carboxymethyl) -cysteine - Google Patents
Preparation method of S- (carboxymethyl) -cysteine Download PDFInfo
- Publication number
- CN110452142B CN110452142B CN201910853513.XA CN201910853513A CN110452142B CN 110452142 B CN110452142 B CN 110452142B CN 201910853513 A CN201910853513 A CN 201910853513A CN 110452142 B CN110452142 B CN 110452142B
- Authority
- CN
- China
- Prior art keywords
- product
- machine body
- filter screen
- cysteine
- steel wire
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- GBFLZEXEOZUWRN-UHFFFAOYSA-N carbocisteine Chemical compound OC(=O)C(N)CSCC(O)=O GBFLZEXEOZUWRN-UHFFFAOYSA-N 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 239000000047 product Substances 0.000 claims abstract description 40
- 239000012065 filter cake Substances 0.000 claims abstract description 35
- 238000006243 chemical reaction Methods 0.000 claims abstract description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 24
- 238000000034 method Methods 0.000 claims abstract description 15
- VLSOAXRVHARBEQ-UHFFFAOYSA-N [4-fluoro-2-(hydroxymethyl)phenyl]methanol Chemical compound OCC1=CC=C(F)C=C1CO VLSOAXRVHARBEQ-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000003513 alkali Substances 0.000 claims abstract description 11
- 239000003638 chemical reducing agent Substances 0.000 claims abstract description 11
- 239000012043 crude product Substances 0.000 claims abstract description 11
- 239000000203 mixture Substances 0.000 claims abstract description 11
- 238000010438 heat treatment Methods 0.000 claims abstract description 10
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229940106681 chloroacetic acid Drugs 0.000 claims abstract description 9
- 230000008569 process Effects 0.000 claims abstract description 9
- 239000002253 acid Substances 0.000 claims abstract description 8
- 239000007864 aqueous solution Substances 0.000 claims abstract description 7
- 150000007524 organic acids Chemical class 0.000 claims abstract description 4
- 229910000831 Steel Inorganic materials 0.000 claims description 27
- 239000010959 steel Substances 0.000 claims description 27
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 21
- 238000001035 drying Methods 0.000 claims description 15
- 239000000243 solution Substances 0.000 claims description 15
- 238000001914 filtration Methods 0.000 claims description 14
- 229920006332 epoxy adhesive Polymers 0.000 claims description 13
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 9
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 9
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical group [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 8
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 claims description 8
- 229960003067 cystine Drugs 0.000 claims description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 7
- 235000019393 L-cystine Nutrition 0.000 claims description 7
- 239000004158 L-cystine Substances 0.000 claims description 7
- UIIMBOGNXHQVGW-UHFFFAOYSA-M sodium bicarbonate Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 6
- 230000009471 action Effects 0.000 claims description 5
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 4
- QIJRTFXNRTXDIP-UHFFFAOYSA-N (1-carboxy-2-sulfanylethyl)azanium;chloride;hydrate Chemical compound O.Cl.SCC(N)C(O)=O QIJRTFXNRTXDIP-UHFFFAOYSA-N 0.000 claims description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 3
- 229960000583 acetic acid Drugs 0.000 claims description 3
- 229960001305 cysteine hydrochloride Drugs 0.000 claims description 3
- 239000012362 glacial acetic acid Substances 0.000 claims description 3
- 239000003960 organic solvent Substances 0.000 claims description 3
- 238000006722 reduction reaction Methods 0.000 claims description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 229910021529 ammonia Inorganic materials 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 5
- 239000000126 substance Substances 0.000 abstract description 3
- 150000001875 compounds Chemical class 0.000 abstract description 2
- 238000002425 crystallisation Methods 0.000 abstract 1
- 230000008025 crystallization Effects 0.000 abstract 1
- 238000003756 stirring Methods 0.000 description 12
- 238000001816 cooling Methods 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- GBFLZEXEOZUWRN-VKHMYHEASA-N S-carboxymethyl-L-cysteine Chemical compound OC(=O)[C@@H](N)CSCC(O)=O GBFLZEXEOZUWRN-VKHMYHEASA-N 0.000 description 6
- 229960004399 carbocisteine Drugs 0.000 description 6
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 5
- 235000011114 ammonium hydroxide Nutrition 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- LJPYJRMMPVFEKR-UHFFFAOYSA-N prop-2-ynylurea Chemical compound NC(=O)NCC#C LJPYJRMMPVFEKR-UHFFFAOYSA-N 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 4
- 238000002386 leaching Methods 0.000 description 4
- 210000003097 mucus Anatomy 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 238000007670 refining Methods 0.000 description 4
- 239000011343 solid material Substances 0.000 description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 241000521257 Hydrops Species 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 210000000959 ear middle Anatomy 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 150000004681 metal hydrides Chemical class 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 210000003928 nasal cavity Anatomy 0.000 description 2
- 229910052755 nonmetal Inorganic materials 0.000 description 2
- 210000003695 paranasal sinus Anatomy 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 238000004904 shortening Methods 0.000 description 2
- 239000001117 sulphuric acid Substances 0.000 description 2
- 235000011149 sulphuric acid Nutrition 0.000 description 2
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 206010009137 Chronic sinusitis Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 229910010084 LiAlH4 Inorganic materials 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical group 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 208000027157 chronic rhinosinusitis Diseases 0.000 description 1
- 210000000254 ciliated cell Anatomy 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910052987 metal hydride Inorganic materials 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000000420 mucociliary effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 150000002843 nonmetals Chemical class 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 208000005923 otitis media with effusion Diseases 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000012749 thinning agent Substances 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- WCTAGTRAWPDFQO-UHFFFAOYSA-K trisodium;hydrogen carbonate;carbonate Chemical compound [Na+].[Na+].[Na+].OC([O-])=O.[O-]C([O-])=O WCTAGTRAWPDFQO-UHFFFAOYSA-K 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910853513.XA CN110452142B (en) | 2019-09-10 | 2019-09-10 | Preparation method of S- (carboxymethyl) -cysteine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910853513.XA CN110452142B (en) | 2019-09-10 | 2019-09-10 | Preparation method of S- (carboxymethyl) -cysteine |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110452142A CN110452142A (en) | 2019-11-15 |
CN110452142B true CN110452142B (en) | 2020-08-21 |
Family
ID=68491503
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910853513.XA Active CN110452142B (en) | 2019-09-10 | 2019-09-10 | Preparation method of S- (carboxymethyl) -cysteine |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110452142B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114746399B (en) * | 2019-11-29 | 2024-05-24 | 武汉远大弘元股份有限公司 | Preparation method of carbocisteine |
CN111138326A (en) * | 2019-12-31 | 2020-05-12 | 宁波市远发生物工程有限公司 | Preparation method of S-carboxymethyl-L-cysteine |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2501852B2 (en) * | 1988-01-29 | 1996-05-29 | 昭和電工株式会社 | Process for producing S-carboxymethyl-L-cysteine |
CN1159474C (en) * | 2000-12-14 | 2004-07-28 | 刘德海 | Productive technology for directly synthesizing S-carboxymethyl-L-semicystine by electrolyzing L-cystine in alkaline medium |
CN105418471B (en) * | 2015-12-24 | 2017-09-05 | 宜昌三峡制药有限公司 | A kind of synthetic method of carbocisteine |
CN106083673B (en) * | 2016-06-29 | 2017-11-03 | 罗江晨明生物制品有限公司 | A kind of preparation technology of carbocisteine |
CN106565565B (en) * | 2016-10-19 | 2018-08-03 | 武汉远大弘元股份有限公司 | A kind of preparation method of carbocisteine |
CN109053508B (en) * | 2018-09-19 | 2020-08-07 | 云鹏医药集团有限公司 | Preparation method of carbocisteine |
-
2019
- 2019-09-10 CN CN201910853513.XA patent/CN110452142B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN110452142A (en) | 2019-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110452142B (en) | Preparation method of S- (carboxymethyl) -cysteine | |
CN107293695B (en) | method for rapidly synthesizing ternary lithium battery positive electrode material precursor by double kettles | |
JP2023552175A (en) | Impurity removal and treatment method in the recovery process of waste cathode materials of lithium batteries | |
CN109354077A (en) | A kind of ternary precursor and preparation method thereof of polycrystalline form | |
BR112019012537A2 (en) | iron recovery method from zinc sulfate solution | |
CN107892644A (en) | A kind of method that xylitol is reclaimed from more subcrystalline Xylitol mother liquor | |
CN110344081B (en) | Method for preparing high-purity gallium by wet chemical-electrochemical combined refining | |
WO2011009352A1 (en) | Method for preparing manganese carbonate | |
CN105838879B (en) | From the method and apparatus for removing removing calcium and magnesium after the heavy indium of zinc abstraction in liquid | |
CN109850958A (en) | A kind of discarded printed nickel net recovery and treatment method | |
CN105132512B (en) | A kind of method that impurity tailing peak is reduced in terramycin production | |
CN104987311A (en) | Preparing method for (4-(4-cyclopropyl-naphthalene-1-yl)-5-nitr-4H-(1, 2, 4) triazole-3-ylsulfanyl)-ethyl acetate and intermediate (5-nitr-4H-(1, 2, 4) triazole-3-sulfenyl)-ethyl acetate thereof | |
CN106987608A (en) | A kind of crystallization in motion of calcium gluconae | |
CN111138326A (en) | Preparation method of S-carboxymethyl-L-cysteine | |
CN207957787U (en) | A kind of potassium nitrate equipment for purifying | |
CN105061327B (en) | A kind of synthetic method of sulfamethoxyplridazine | |
CN209645888U (en) | A kind of xylose crystalline auxiliary cooling device | |
CN113773413A (en) | Efficient extraction method of hyaluronic acid fermentation liquor | |
CN105232457A (en) | Method for preparing doramectin sterile solution | |
CN213771870U (en) | Soak device is used in corn starch production and processing | |
CN108455669A (en) | A kind of preparation method of schlippe's salt | |
CN103694280A (en) | Method for extracting glucosamine hydrochloride from glucosamine hydrochloride-containing mother liquor | |
CN109400491A (en) | A kind of crystallization preparation method of D-HPG methyl esters | |
CN108623579B (en) | Synthesis method of piroxicam | |
CN207517786U (en) | A kind of preparation facilities of nickel-cobalt-manganese ternary presoma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20200320 Address after: 102600 Beijing Daxing District Zhongguancun Science and Technology Park Daxing Biomedical Industry Base No. 22 Yongwang Road, 4 1-2 floors Applicant after: Wu Chuanming Address before: 041500 No.19 Yunpeng Avenue, Xiangfen Pharmaceutical Industrial Park, Linfen City, Shanxi Province Applicant before: Yunpeng Pharmaceutical Group Co., Ltd |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20200408 Address after: 102600 Beijing Daxing District Zhongguancun Science and Technology Park Daxing Biomedical Industry Base No. 22 Yongwang Road, 4 1-2 floors Applicant after: Beijing Yunpeng Pengcheng Pharmaceutical Technology Co., Ltd. Address before: 102600 Beijing Daxing District Zhongguancun Science and Technology Park Daxing Biomedical Industry Base No. 22 Yongwang Road, 4 1-2 floors Applicant before: Wu Chuanming |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20200728 Address after: 041500 No.19 Yunpeng Avenue, Xiangfen Pharmaceutical Industrial Park, Linfen City, Shanxi Province Applicant after: Yunpeng Pharmaceutical Group Co.,Ltd. Address before: 102600 Beijing Daxing District Zhongguancun Science and Technology Park Daxing Biomedical Industry Base No. 22 Yongwang Road, 4 1-2 floors Applicant before: Beijing Yunpeng Pengcheng Pharmaceutical Technology Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210402 Address after: 102600 Beijing Daxing District Zhongguancun Science and Technology Park Daxing Biomedical Industry Base No. 22 Yongwang Road, 4 1-2 floors Patentee after: Beijing Yunpeng Pengcheng Pharmaceutical Technology Co.,Ltd. Address before: No.19 Yunpeng Avenue, Xiangfen Pharmaceutical Industrial Park, Linfen City, Shanxi Province 041500 Patentee before: Yunpeng Pharmaceutical Group Co.,Ltd. |